|
531686 ADVIKLA Group (XT) 10 Aug,12:14
1.99
0.09 (4.74%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
Invest & Trade in ADVIKLA on dhan
2 min read
11 hours ago
1 min read
2 days ago
2 min read
4 hours ago
1 min read
6 hours ago
| Mar ' 26 | Mar ' 25 | Mar ' 24 | Mar ' 23 | Mar ' 22 | |
|---|---|---|---|---|---|
| Sales | - | - | - | - | 0.03 |
| Operating profit | -0.95 | -0.76 | -0.80 | -0.95 | -0.68 |
| Interest | - | - | - | - | - |
| Gross profit | -0.91 | -0.72 | -0.71 | -0.93 | -0.42 |
| EPS (Rs) | -0.53 | -0.47 | -0.43 | -0.55 | -0.07 |
2 min read
4 hours ago
1 min read
5 hours ago
Q: What is the current share price of MPS Pharma Ltd.?
A: The current share price of MPS Pharma Ltd. is ₹ 1.99 (for BSE as on 10 Aug,12:14). The 52-week range is ₹ 2.47 - 1.57. Prices are updated based on live market data.
Q: What is the market capitalization of MPS Pharma Ltd.?
A: MPS Pharma Ltd. has a market capitalization of ₹ 3.81 Cr, making it a company.
Q: What is the PE ratio of MPS Pharma Ltd.?
A: The Price-to-Earnings (PE) ratio of MPS Pharma Ltd. is -3.73, indicating its valuation relative to earnings.
Q: Is MPS Pharma Ltd. a good investment?
A: MPS Pharma Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: What are the latest financial results of MPS Pharma Ltd.?
A: MPS Pharma Ltd. has reported its latest annual results with revenue of ₹ - and net profit/loss of ₹ -1.02.
